Posts

Showing posts with the label Clinical Laboratory Tests Market Share

Clinical Laboratory Tests Market Size Is Expected To Reach USD 213.04 Billion By 2030

Image
  San Francisco, 7 Feb 2024:  The Report  Clinical Laboratory Tests Market  Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/ HCT testing), By End-Use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030 The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, registering a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment. The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According

Clinical Laboratory Tests Market Size To Hit USD 286.7 Billion By 2026 : Grand View Research Inc.

San Francisco, 19  August 2019:   The Report   Clinical Laboratory Tests Market   Analysis Report By Type (CBC, HGB/HCT, BMP, HbA1c Testing, Electrolyte Testing, Liver Panel), By End Use (Primary Clinics, Central Labs), And Segment Forecasts, 2019 – 2026 The global clinical laboratory tests market size is expected to reach USD 286.7 billion by 2026 at a 7.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel solutions for maximizing efficiency and minimizing errors is expected to boost the market. Presence of favorable reimbursement policies is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association, clinical laboratory tests are reimbursed by Medicare beneficiaries either under the Clinical Laboratory Fee Schedule or Physician Fee Schedule depending on the nature of service. Rising demand for early detection is anticipated to propel the mar